laurocapram has been researched along with Herpes Simplex Virus Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afouna, MI; Fincher, TK; Reddy, IK; Zaghloul, AA | 1 |
| Clark, DS; Gaede, P; McKeough, M; Robertson, F; Spruance, SL; Sugibayashi, K | 1 |
| Beaman, DC; Kumar, A; Leonard, MF; Murray, DL | 1 |
| Baker, DC; Flynn, GL; Fox, JL; Higuchi, WI; Ho, NF; Kumar, SD; Shannon, WM; Sugibayashi, K; Vaidyanathan, R; Westbrook, L | 1 |
4 other study(ies) available for laurocapram and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Administration, Topical; Animals; Antiviral Agents; Azepines; Cidofovir; Cytosine; Drug Administration Schedule; Female; Herpes Simplex; Herpesvirus 1, Human; Mice; Mice, Hairless; Organophosphonates; Organophosphorus Compounds; Permeability; Skin Absorption | 2003 |
Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs.
Topics: Administration, Topical; Animals; Azepines; Diffusion; Female; Guinea Pigs; Herpes Simplex; Pharmaceutical Vehicles; Propylene Glycol; Propylene Glycols; Skin Absorption; Skin Diseases, Infectious; Thymidine; Trifluridine | 1984 |
Inhibitory effect of Azone (1-dodecylazacycloheptan-2-one) on herpes simplex viruses. In vivo and in vitro studies.
Topics: Animals; Antiviral Agents; Azepines; Guinea Pigs; Herpes Simplex; Simplexvirus | 1987 |
Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Azepines; Chromatography, Thin Layer; Diffusion; Herpes Simplex; Mice; Mice, Hairless; Permeability; Skin Absorption; Time Factors; Vidarabine | 1985 |